Large B-cell lymphoma with Hodgkin's features

Histopathology

Volumn 47, Issue 1, 2005, Pages 101-110

  Mollejo, M ^a   Fraga, M ^b   Forteza, J ^c   Muniesa, J A ^c   Perez Guillermo M ^d   Perez Seoane C ^e   Rivera, T ^f   Ortega, P ^g   Piris, M A ^h   Garcia, Juan F ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b HOSPITAL VIRGEN DE LA SALUD   (Spain)

^c Instituto de Salud Carlos III   (Spain)

^d HOSPITAL OBISPO POLANCO   (Spain)

^e Allergy Section   (Spain)

^f HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^g HOSPITAL DE MÓSTOLES   (Spain)

^h HOSPITAL GENERAL DE SEGOVIA   (Spain)

Author keywords

Aggressive lymphomas; Hodgkin's lymphoma; Immunohistochemistry; Large B cell lymphoma; NF B

Indexed keywords

CD15 ANTIGEN; CD20 ANTIGEN; CD30 ANTIGEN; CD45 ANTIGEN; CD79A ANTIGEN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOCYTE ANTIGEN; MEMBRANE PROTEIN; OCT2 ANTIGEN; PROTEIN SUBUNIT; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR REL P65 SUBUNIT; UNCLASSIFIED DRUG; VIRUS LATENT MEMBRANE PROTEIN; VIRUS PROTEIN;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BCL6 GENE; CANCER GROWTH; CASE REPORT; CHROMOSOME 3Q; CLINICAL FEATURE; DIFFUSE LARGE B CELL LYMPHOMA; FEMALE; GENE; GENE MUTATION; GENE REARRANGEMENT; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LARGE B CELL LYMPHOMA; LARGE CELL LYMPHOMA; MALE; MEDIASTINUM TUMOR; MORPHOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REED STERNBERG CELL; TUMOR SUPPRESSOR GENE;

ADULT; AGED; ANTIGENS, CD; DIAGNOSIS, DIFFERENTIAL; DNA-BINDING PROTEINS; FEMALE; GENE REARRANGEMENT; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KI-67 ANTIGEN; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; MUTATION; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-BCL-6; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

HUMAN HERPESVIRUS 4;

EID: 22144477212     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2005.02175.x     Document Type: Article

References (29)

1. Jaffe ESHN, Stein H, Vardiman JW. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization classification of tumours. Lyon: IARC Press 2001.
2. Rüdiger T, Jaffe ES, Delsol G et al Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma). Ann. Oncol. 1998; 9 (Suppl. 5); S31-38.
3. Traverse-Glehen APS, Vivero A, Raffeld M, Jaffe ES. Mediastinal grey zone lymphoma: the missing link between classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma. Mod. Pathol 2004; 17 (Suppl. 1); 274A.
4. Higgins JP, Warnke RA. CD30 expression is common in mediastinal large B-cell lymphoma. Am. J. Clin. Pathol. 1999; 112; 241-247.
5. Chadburn A, Frizzera G. Mediastinal large B-cell lymphoma vs classic Hodgkin lymphoma. Am. J. Clin. Pathol 1999; 112; 155-158.
6. Deacon EMG, Pallesen G Niedobitek et al. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J. Exp. Med. 1993; 177; 339-349.
7. Hinz M, Loser P, Mathas S et al. Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells. Blood 2001; 97; 2798-2807.
8. Bargou RC, Emmerich F, Krappmann D et al. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J. Clin. Invest. 1997; 100; 2961-2969.
9. van Dongen JJ, Langerak AW, Bruggemann M et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003; 17; 2257-2317.
10. Martin-Subero JI, Harder L, Gesk S et al. Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain loci. Int. J. Cancer 2002; 98; 470-474.
11. Villuendas R, Piris MA, Algara P et al. The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations. Blood 1993; 82; 3151-3156.
12. Savage KJ, Monti S, Kutok JL et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 2003; 102; 3871-3879.
13. Emmerich F, Meiser M, Hummel M et al. Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells. Blood 1999; 94; 3129-3134.
14. Stein H, Marafioti T, Foss HD et al. Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood 2001; 97; 496-501.
15. Saez AI, Artiga MJ, Sanchez-Beato M et al. Analysis of octamer-binding transcription factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in lymphomas. Mod. Pathol. 2002; 15; 211-220.
16. Pileri S. Controversies on Hodgkin's disease and anaplastic large cell lymphoma. Hematopathology Study Group of the Societa Italiana di Anatomia Patologica. Haematologica 1994; 79; 299-310.
17. Macs B, Anastasopoulou A, Kluin-Nelemans JC et al. Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features. Ann. Oncol 2001; 12; 853-858.
18. Haioun C, Gaulard P, Roudot-Thoraval F et al. Mediastinal diffuse large-cell lymphoma with sclerosis: a condition with a poor prognosis. Am. J. Clin. Oncol 1989; 12; 425-429.
19. Lamarre L, Jacobson JO, Aisenberg AC, Harris NL. Primary large cell lymphoma of the mediastinum. A histologic and immunophenotypic study of 29 cases. Am. J. Surg. Pathol. 1989; 13; 730-739.
20. Pileri SA, Gaidano G, Zinzani PL et al. Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. Am. J. Pathol. 2003; 162; 243-253.
21. Copie-Bergman C, Gaulard P, Maouche-Chretien L et al. The MAL gene is expressed in primary mediastinal large B-cell lymphoma. Blood 1999; 94; 3567-3575.
22. Saez AI, Saez AJ, Artiga MJ et al. Building an outcome predictor model for diffuse large B-cell lymphoma. Am. J. Pathol. 2004; 164; 613-622.
23. Copie-Bergman C, Plonquet A, Alonso MA et al. MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas. Mod. Pathol. 2002; 15; 1172-1180.
24. Browne P, Petrosyan K, Hernandez A, Chan JA. The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma. Am. J. Clin. Pathol. 2003; 120; 767-777.
25. Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999; 18; 6853-6866.
26. Garcia JF, Camacho FI, Morente M et al. Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays. Blood 2003; 101; 681-689.
27. Sanchez-Beato M, Sanchez-Aguilera A, Piris MA. Cell cycle deregulation in B-cell lymphomas. Blood 2003; 101; 1220-1235.
28. Maggio EM, Stekelenburg E, Van den Berg A, Poppema S. TP53 gene mutations in Hodgkin lymphoma are infrequent and not associated with absence of Epstein-Barr virus. Int. J. Cancer 2001; 94; 60-66.
29. Wlodarska I, Nooyen P, Maes B et al. Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma. Blood 2003; 101; 706-710.